Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2020

Feb 10, 2021

SELL
$99.61 - $142.12 $24,802 - $35,387
-249 Closed
0 $0
Q3 2020

Oct 26, 2020

SELL
$72.92 - $102.01 $34,418 - $48,148
-472 Reduced 65.46%
249 $25,000
Q2 2020

Aug 11, 2020

SELL
$55.75 - $92.75 $3,623 - $6,028
-65 Reduced 8.27%
721 $63,000
Q1 2020

May 06, 2020

SELL
$37.9 - $104.44 $606 - $1,671
-16 Reduced 2.0%
786 $46,000
Q3 2019

Nov 12, 2019

BUY
$90.37 - $122.49 $48,076 - $65,164
532 Added 197.04%
802 $72,000
Q2 2019

Aug 08, 2019

SELL
$89.51 - $118.04 $1,790 - $2,360
-20 Reduced 6.9%
270 $32,000
Q4 2018

Feb 12, 2019

BUY
$56.04 - $82.66 $16,251 - $23,971
290 New
290 $18,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.2B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Morgan Dempsey Capital Management LLC Portfolio

Follow Morgan Dempsey Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Dempsey Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Dempsey Capital Management LLC with notifications on news.